{"id":"https://openalex.org/W9256820","doi":"https://doi.org/10.1182/blood.v122.21.1458.1458","title":"Arginine Deprivation With Pegylated Arginine Deiminase Induces Death Of Acute Myeloid Leukaemia Cells In Vivo","display_name":"Arginine Deprivation With Pegylated Arginine Deiminase Induces Death Of Acute Myeloid Leukaemia Cells In Vivo","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W9256820","doi":"https://doi.org/10.1182/blood.v122.21.1458.1458","mag":"9256820"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.1458.1458","doi":"https://doi.org/10.1182/blood.v122.21.1458.1458","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1458.1458","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066521737","display_name":"Farideh Miraki\u2010Moud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Farideh Miraki-Moud","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046963415","display_name":"Linda Ariza\u2010McNaughton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Linda Ariza-McNaughton","raw_affiliation_strings":["Haematopoietic Stem Cell Laboratory, Cancer Research UK, London, United Kingdom,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematopoietic Stem Cell Laboratory, Cancer Research UK, London, United Kingdom,","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026718910","display_name":"Essam Ahmed Ghazaly","orcid":"https://orcid.org/0000-0003-4368-8565","observed_orcids":["https://orcid.org/0000-0003-4368-8565"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Essam A Ghazaly","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064287027","display_name":"Katharine A. Hodby","orcid":"https://orcid.org/0009-0005-8566-8927","observed_orcids":["https://orcid.org/0009-0005-8566-8927"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Katharine A Hodby","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102851603","display_name":"Phuong Luong","orcid":"https://orcid.org/0000-0002-6776-9610","observed_orcids":["https://orcid.org/0000-0002-6776-9610"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Phuong Luong","raw_affiliation_strings":["Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary, University of London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary, University of London, London, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082370164","display_name":"Andrew James Clear","orcid":"https://orcid.org/0000-0001-8246-5642","observed_orcids":["https://orcid.org/0000-0001-8246-5642"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Andrew Clear","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022945467","display_name":"Fareeda Sohrabi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Fareeda Sohrabi","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007808102","display_name":"John S. Bomalaski","orcid":"https://orcid.org/0000-0002-9454-7271","observed_orcids":["https://orcid.org/0000-0002-9454-7271"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John Bomalaski","raw_affiliation_strings":["Polaris Group, San Diego, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Polaris Group, San Diego, CA, USA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067154165","display_name":"John G. Gribben","orcid":"https://orcid.org/0000-0002-8505-7430","observed_orcids":["https://orcid.org/0000-0002-8505-7430"]},"institutions":[{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Gribben","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute, London, United Kingdom,","institution_ids":["https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016016794","display_name":"Dominique A. Bonnet","orcid":"https://orcid.org/0000-0002-4735-5226","observed_orcids":["https://orcid.org/0000-0002-4735-5226"]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dominique Bonnet","raw_affiliation_strings":["Haematopoietic Stem Cell Laboratory, Cancer Research UK, London, United Kingdom,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematopoietic Stem Cell Laboratory, Cancer Research UK, London, United Kingdom,","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022032908","display_name":"Peter Wojciech Szlosarek","orcid":"https://orcid.org/0000-0002-5039-711X","observed_orcids":["https://orcid.org/0000-0002-5039-711X"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Peter Szlosarek","raw_affiliation_strings":["Centre of Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039475933","display_name":"David Christopher Taussig","orcid":"https://orcid.org/0000-0002-6653-7308","observed_orcids":["https://orcid.org/0000-0002-6653-7308"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David C Taussig","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5007808102","https://openalex.org/A5022032908","https://openalex.org/A5022945467","https://openalex.org/A5026718910","https://openalex.org/A5046963415","https://openalex.org/A5064287027","https://openalex.org/A5066521737","https://openalex.org/A5082370164","https://openalex.org/A5102851603"],"corresponding_institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801316944","https://openalex.org/I4405264518"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.213,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.55419184,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"122","issue":"21","first_page":"1458","last_page":"1458"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.6455000042915344,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.6455000042915344,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.21940000355243683,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.058800000697374344,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9660000205039978},{"id":"https://openalex.org/keywords/arginine-deprivation","display_name":"arginine deprivation","score":0.8769999742507935},{"id":"https://openalex.org/keywords/pegylated-arginine-deiminase","display_name":"pegylated arginine deiminase","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.8560000061988831},{"id":"https://openalex.org/keywords/argininosuccinate-synthetase-1","display_name":"argininosuccinate synthetase 1","score":0.9120000004768372},{"id":"https://openalex.org/keywords/amino-acid-metabolism","display_name":"amino acid metabolism","score":0.765999972820282},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7400000095367432},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6899999976158142},{"id":"https://openalex.org/keywords/plasma-arginine","display_name":"plasma arginine","score":0.7699999809265137},{"id":"https://openalex.org/keywords/leukemia-cell-death","display_name":"leukemia cell death","score":0.6029999852180481},{"id":"https://openalex.org/keywords/nsg-mice","display_name":"NSG mice","score":0.6100000143051147},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.3540000021457672}],"concepts":[{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.86129230260849},{"id":"https://openalex.org/C188610204","wikidata":"https://www.wikidata.org/wiki/Q24741403","display_name":"Argininosuccinate synthase","level":5,"score":0.7282924056053162},{"id":"https://openalex.org/C2777468819","wikidata":"https://www.wikidata.org/wiki/Q173670","display_name":"Arginine","level":3,"score":0.6461824774742126},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5574181079864502},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5046669244766235},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48960286378860474},{"id":"https://openalex.org/C2777186326","wikidata":"https://www.wikidata.org/wiki/Q24722788","display_name":"Arginine deiminase","level":4,"score":0.47344183921813965},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.45613744854927063},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.42542898654937744},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.41503381729125977},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3439386487007141},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33596163988113403},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2966741621494293},{"id":"https://openalex.org/C2779129087","wikidata":"https://www.wikidata.org/wiki/Q408641","display_name":"Citrulline","level":4,"score":0.20005160570144653},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19539359211921692},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18544089794158936},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.18335646390914917},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.1458.1458","doi":"https://doi.org/10.1182/blood.v122.21.1458.1458","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1458.1458","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1968261414","https://openalex.org/W843220732","https://openalex.org/W2042560747","https://openalex.org/W3193674771","https://openalex.org/W794292892","https://openalex.org/W2753622326","https://openalex.org/W3140900363","https://openalex.org/W2979546414","https://openalex.org/W2081060988","https://openalex.org/W2015417449"],"abstract_inverted_index":{"Abstract":[0,350],"Introduction":[1],"Malignant":[2],"cells":[3,50,84],"require":[4],"amino":[5],"acids":[6],"for":[7,30,128,135,333],"a":[8,56,86,212,272,329],"wide":[9],"range":[10],"of":[11,52,71,89,110,159,206,217,227,240,267],"core":[12],"functions.":[13],"Amino":[14,32],"acid":[15,33],"deprivation":[16,34,249],"using":[17,177],"enzymatic":[18],"degradation":[19],"has":[20],"been":[21],"used":[22],"to":[23,144,173,220,287],"induce":[24],"remission":[25],"in":[26,59,85,146,161,198,215,238,258,278,293],"acute":[27,40,336],"lymphoblastic":[28],"leukemia":[29,42],"decades.":[31],"may":[35],"also":[36],"benefit":[37],"patients":[38],"with":[39,101,261,269,291],"myeloid":[41,337],"(AML).":[43],"We":[44],"have":[45],"previously":[46],"shown":[47],"that":[48,62,193,247],"AML":[49,83,104,111,160,218,263],"lack":[51],"argininosuccinate":[53,334],"synthetase":[54],"1(ASS1),":[55],"key":[57],"enzyme":[58],"the":[60,69,157,162,204,225,255,280,285],"pathway":[61],"produces":[63],"arginine":[64,73,77,176,184,194,248,324],"(1).":[65],"Here":[66],"we":[67],"tested":[68],"effect":[70,274],"an":[72],"depleting":[74],"agent,":[75],"pegylated":[76],"deiminase":[78,325],"(ADI-PEG":[79,326],"20)":[80,327],"on":[81],"primary":[82,103,262],"xenograft":[87],"model":[88],"AML.":[90],"Methods":[91],"NOD/SCID/interleukin":[92],"2":[93],"gamma":[94],"chain":[95],"null":[96],"(NSG)":[97],"mice":[98,112,153,259],"were":[99,154,186],"transplanted":[100,260],"6":[102],"samples.":[105],"12":[106],"weeks":[107,149],"after":[108,150],"transplantation":[109],"received":[113],"either":[114],"ADI-PEG":[115,118,189,207,228,251,289],"20,":[116],"cytarabine,":[117],"20":[119,190,208,229,252,290],"plus":[120],"cytarabine":[121,132,210,231,236,270,276,292],"or":[122],"vehicle.":[123],"ADI":[124,268],"was":[125,133,165,171,196,232],"administered":[126],"weekly":[127],"4":[129],"doses":[130],"and":[131,156,209,230,320,355,362],"given":[134],"10":[136],"consecutive":[137],"days":[138],"(0.2mg":[139],"per":[140],"day,":[141],"roughly":[142],"equivalent":[143],"40mg":[145],"humans).":[147],"Five":[148],"treatment":[151],"started,":[152],"killed":[155],"percentage":[158],"bone":[163],"marrow":[164],"determined":[166],"by":[167,250],"flow":[168],"cytometry.":[169],"Blood":[170],"collected":[172],"quantify":[174],"plasma":[175],"liquid":[178],"chromatography-mass":[179],"spectrometry/mass":[180],"spectrometry.":[181],"Results":[182],"Plasma":[183],"levels":[185,216],"depressed":[187],"following":[188],"administration":[191],"confirming":[192],"depletion":[195],"achieved":[197],"vivo.":[199],"In":[200],"all":[201],"six":[202,241],"experiments":[203,245],"combination":[205,226,266],"induced":[211],"significant":[213],"reduction":[214],"compared":[219],"control":[221],"(Figure":[222],"1).":[223],"Critically":[224],"significantly":[233],"better":[234],"than":[235,275],"alone":[237,277],"three":[239],"experiments.":[242,281],"Conclusion":[243],"Our":[244],"show":[246],"can":[253],"decrease":[254],"leukemic":[256],"burden":[257],"cells.":[264],"The":[265],"had":[271],"greater":[273],"half":[279],"These":[282],"results":[283],"provide":[284],"rationale":[286],"test":[288],"clinical":[294],"trials.":[295],"1.":[296],"Peter":[297],"W.":[298],"Szlosarek,":[299],"Fiona":[300],"Luong,":[301],"Andrew":[302],"Clear,":[303],"David":[304],"Taussig,":[305],"Simon":[306],"Joel,":[307],"Maria":[308],"Calaminici,":[309],"Silvana":[310],"Debernardi,":[311],"Jude":[312],"Fitzgibbon,":[313],"John":[314],"S.":[315],"Bomalaski,":[316],"Arthur":[317],"E.":[318],"Frankel,":[319],"Dominique":[321],"Bonnet.":[322],"Pegylated":[323],"as":[328],"potential":[330],"novel":[331],"therapy":[332],"synthetase-deficient":[335],"leukemia.":[338],"Cancer":[339],"Research:":[340],"April":[341],"15,":[342],"2011.":[343],"AACR":[344],"102nd":[345],"Annual":[346],"Meeting":[347],"2011,":[348],"(AACR":[349],"#":[351],"467)":[352],"F.":[353],"M-M":[354],"L.":[356],"A-M":[357],"contributed":[358,364],"equally":[359,365],"D.B.,":[360],"P.W.S.":[361],"D.C.T":[363],"Disclosures:":[366],"Bomalaski:":[367],"Polaris":[368],"Group:":[369,374],"Employment,":[370],"Equity":[371],"Ownership.":[372],"Szlosarek:Polaris":[373],"Research":[375],"Funding.":[376]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}